Literature DB >> 18314492

c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.

José P Vaqué1, Belén Fernández-García, Pablo García-Sanz, Nuria Ferrandiz, Gabriel Bretones, Fernando Calvo, Piero Crespo, María C Marín, Javier León.   

Abstract

Although mutant Ras proteins were originally described as transforming oncoproteins, they induce growth arrest, senescence, and/or differentiation in many cell types. c-Myc is an oncogenic transcription factor that cooperates with Ras in cellular transformation and oncogenesis. However, the Myc-Ras relationship in cellular differentiation is largely unknown. Here, we have analyzed the effects of c-Myc on PC12-derived cells (UR61 cell line), harboring an inducible N-Ras oncogene. In these cells, Ras activation induces neuronal-like differentiation by a process involving c-Jun activation. We found that c-Myc inhibited Ras-mediated differentiation by a mechanism that involves the blockade of c-Jun induction in response to Ras signal. Accordingly, ectopically expressed c-Jun could bypass c-Myc impediment of Ras-induced differentiation and activator protein 1 activation. Interestingly, it did not rescue the proliferative arrest elicited by Ras and did not enhance the differentiation-associated apoptosis. The blockade of Ras-mediated induction of c-Jun takes place at the level of c-Jun proximal promoter. Mutational analysis revealed that c-Myc regions involved in DNA binding and transactivation are required to block differentiation and c-Jun induction. c-Myc does not seem to require Miz-1 to inhibit differentiation and block c-Jun induction. Furthermore, Max is not required for c-Myc activity, as UR61 cells lack a functional Max gene. c-Myc-inhibitory effect on the Ras/c-Jun connection is not restricted to UR61 cells as it can occur in other cell types as K562 or HEK293. In conclusion, we describe a novel interplay between c-Myc and c-Jun that controls the ability of Ras to trigger the differentiation program of pheochromocytoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314492     DOI: 10.1158/1541-7786.MCR-07-0180

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  16 in total

Review 1.  An update on the genetics of pheochromocytoma.

Authors:  D Karasek; U Shah; Z Frysak; C Stratakis; K Pacak
Journal:  J Hum Hypertens       Date:  2012-05-31       Impact factor: 3.012

Review 2.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

3.  Sin3b interacts with Myc and decreases Myc levels.

Authors:  Pablo Garcia-Sanz; Andrea Quintanilla; M Carmen Lafita; Gema Moreno-Bueno; Lucia García-Gutierrez; Vedrana Tabor; Ignacio Varela; Yuzuru Shiio; Lars-Gunnar Larsson; Francisco Portillo; Javier Leon
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

Review 4.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

5.  Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.

Authors:  Iñaki Comino-Méndez; Francisco J Gracia-Aznárez; Francesca Schiavi; Iñigo Landa; Luis J Leandro-García; Rocío Letón; Emiliano Honrado; Rocío Ramos-Medina; Daniela Caronia; Guillermo Pita; Alvaro Gómez-Graña; Aguirre A de Cubas; Lucía Inglada-Pérez; Agnieszka Maliszewska; Elisa Taschin; Sara Bobisse; Giuseppe Pica; Paola Loli; Rafael Hernández-Lavado; José A Díaz; Mercedes Gómez-Morales; Anna González-Neira; Giovanna Roncador; Cristina Rodríguez-Antona; Javier Benítez; Massimo Mannelli; Giuseppe Opocher; Mercedes Robledo; Alberto Cascón
Journal:  Nat Genet       Date:  2011-06-19       Impact factor: 38.330

6.  Expression of cancerous inhibitor of protein phosphatase 2A in human triple negative breast cancer correlates with tumor survival, invasion and autophagy.

Authors:  Shan Li; Ting-Ting Feng; Yang Guo; Xianjun Yu; Qiuyue Huang; Liang Zhang; Wei Tang; Ying Liu
Journal:  Oncol Lett       Date:  2016-11-09       Impact factor: 2.967

7.  The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.

Authors:  M Carmen Lafita-Navarro; Judit Liaño-Pons; Andrea Quintanilla; Ignacio Varela; Rosa Blanco; Fabiana Ourique; Gabriel Bretones; Julia Aresti; Ester Molina; Patrick Carroll; Peter Hurlin; Octavio A Romero; Montse Sanchez-Céspedes; Robert N Eisenman; M Dolores Delgado; Javier León
Journal:  J Biol Chem       Date:  2020-01-09       Impact factor: 5.157

8.  Functional interplay between c-Myc and Max in B lymphocyte differentiation.

Authors:  Mercedes Pérez-Olivares; Alfonsina Trento; Sara Rodriguez-Acebes; Daniel González-Acosta; David Fernández-Antorán; Sara Román-García; Dolores Martinez; Tania López-Briones; Carlos Torroja; Yolanda R Carrasco; Juan Méndez; Ignacio Moreno de Alborán
Journal:  EMBO Rep       Date:  2018-08-20       Impact factor: 8.807

9.  Impact of Reck expression and promoter activity in neuronal in vitro differentiation.

Authors:  Marina Trombetta-Lima; Thais Assis-Ribas; Ricardo C Cintra; Joana D Campeiro; Juliano R Guerreiro; Sheila M B Winnischofer; Isis C C Nascimento; Henning Ulrich; Mirian A F Hayashi; Mari C Sogayar
Journal:  Mol Biol Rep       Date:  2021-02-22       Impact factor: 2.316

10.  Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.

Authors:  J Ren; W Li; L Yan; W Jiao; S Tian; D Li; Y Tang; G Gu; H Liu; Z Xu
Journal:  Br J Cancer       Date:  2011-11-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.